We demonstrate that both SumIL2-Fc and ProIL2 increased CD8 T cells in the tumor without increasing Tregs, thus inducing a high CD8:Treg ratio (Fig. 5a–c and Supplementary Fig. 7i, j). The gene discussed is CD8A; the disease is neoplasm.